Home / Featured Companies / Eli Lilly and Company Historical Data

Eli Lilly and Company (LLY) Financials

Eli Lilly and Company (LLY) Historical Financial Statements and Key Metrics for 1994 - 2024

Full Eli Lilly and Company financials for 1994 - 2024 are available in the US Historical Financials dataset.

All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.

Eli Lilly and Company Income Statements
(in $ 000,000's)
Quarter End Revenue Gross Profit Operating Income Net Income EBITDA EPS
2024-Mar-31 8,768 7,234 (82.5 %) 2,620 (29.9 %) 2,243 (25.6 %) 3,211 2.48
2023-Dec-31 9,353 7,694 (82.3 %) 3,078 (32.9 %) 2,190 (23.4 %) 3,604 2.31
2023-Sep-30 9,499 7,638 (80.4 %) 450 (4.7 %) -57 (-0.6 %) 6,401 -0.06
2023-Jun-30 8,312 6,505 (78.3 %) 2,126 (25.6 %) 1,763 (21.2 %) 2,320 1.95
2023-Mar-31 6,960 5,333 (76.6 %) 1,494 (21.5 %) 1,345 (19.3 %) 1,704 1.49
2022-Dec-31 7,302 5,754 (78.8 %) 1,836 (25.1 %) 1,938 (26.5 %) 2,555 2.04
2022-Sep-30 0 0 (0.0 %) 0 (0.0 %) 0 (0.0 %) 0 0.00
Full historical income statements for 1994 - 2024 is included in the US Historical Financials dataset.

Eli Lilly and Company Balance Sheets
(in $ 000,000's)
Quarter End Total Assets Total Liabilities Total Debt Total Equity Cash & Equivalents
2024-Mar-31 63,944 51,046 26,211 12,812 2,586
2023-Dec-31 64,006 53,143 25,225 10,772 2,928
2023-Sep-30 57,916 46,608 20,168 11,220 2,494
2023-Jun-30 54,814 43,665 18,820 11,064 2,829
2023-Mar-31 53,163 41,868 18,884 11,190 3,669
2022-Dec-31 49,490 38,714 16,239 10,650 2,212
2022-Sep-30 47,462 37,296 15,888 10,070 2,742
Full historical balance sheet data for 1994 - 2024 is included in the US Historical Financials dataset.

Eli Lilly and Company Cash Flow Statements
(in $ 000,000's)
Quarter End Operating Cash Flow Investing Financing Free Cash Flow
2024-Mar-31 1,166 -1,178 -311 180
2023-Dec-31 -312 -2,924 3,545 -1,963
2023-Sep-30 2,190 -3,080 572 -1,812
2023-Jun-30 632 -459 -1,033 -204
2023-Mar-31 1,731 -689 412 827
2022-Dec-31 1,580 -860 -1,141 1,024
2022-Sep-30 2,185 -923 -1,263 1,565
Full historical cash flow data for 1994 - 2024 is included in the US Historical Financials dataset.

Eli Lilly and Company Key Valuation and Operating Metrics
Quarter End Market Capitalization
($ 000,000's)
Enterprise Value
($ 000,000's)
Price/Earnings
($ 000,000's)
Price/Sales
($ 000,000's)
Price/Book
($ 000,000's)
2024-Mar-31 685,103 708,855 78.14 76.36 53.47
2023-Dec-31 553,412 575,819 59.17 63.18 51.38
2023-Sep-30 483,310 501,097 50.88 -2,105.01 43.07
2023-Jun-30 421,941 438,067 50.76 59.83 38.14
2023-Mar-31 310,205 325,543 44.57 57.66 27.72
2022-Dec-31 347,615 361,786 47.61 44.85 32.64
2022-Sep-30 0 0 0.00 0.00 0.00
Full historical valuation and operating metrics for 1994 - 2024 are included in the US Historical Financials dataset.